Increasing Percutaneous Coronary Interventions for ST-Segment Elevation Myocardial Infarction in the United States Progress and Opportunity by Shah, Rashmee U. et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 4 . 0 7 . 0 1 7CLINICAL RESEARCHIncreasing Percutaneous Coronary
Interventions for ST-Segment Elevation
Myocardial Infarction in the United States
Progress and OpportunityRashmee U. Shah, MD, MS,* Timothy D. Henry, MD,yz Stephanie Rutten-Ramos, DVM, PHD,
Ross F. Garberich, MS,z Mourad Tighiouart, PHD,y C. Noel Bairey Merz, MDyxABSTRACTFro
Lo
the
by
HL
Re
Gu
bu
Ce
Me
ProOBJECTIVES The aim of this study was to quantify changes in percutaneous coronary intervention (PCI) and mortality
rates for ST-segment elevation myocardial infarction (STEMI), and the proportion of hospitals providing STEMI-related
PCI in the United States.
BACKGROUND Health care systems have recently emphasized rapid access to PCI for STEMI, but the effects of these
efforts in a broad population are unknown.
METHODS We used the Nationwide Inpatient Sample, a discharge database representative of all short-term, nonfederal
hospitals in the United States. STEMI discharges were included based on primary discharge diagnosis. We calculated the
adjusted odds ratio (OR) of PCI and in-hospital death over time and the changing proportion of hospitals providing
STEMI-related PCI.
RESULTS From 2003 to 2011, STEMI accounted for 380,254 hospital discharges. The rate of PCI increased from
53.6% to 80.0% with an adjusted OR of 4.16 (95% conﬁdence interval [CI]: 3.71 to 4.66) in 2011 compared with
2003. The proportion of hospitals providing STEMI-related PCI increased from 25.1% in 2003 to 33.7% in 2011. In-
hospital death rates ranged from 7.2% to 9.5%, with the lowest rate in 2009. The OR of death decreased from 2003
to 2011 (adjusted OR: 0.79 in 2011 compared with 2003; 95% CI: 0.74 to 0.84). After accounting for PCI, the OR of
in-hospital death did not change between 2003 and 2011 (adjusted OR: 1.01 in 2011 compared with 2003; 95% CI:
0.95 to 1.07).
CONCLUSIONS PCI rates and hospitals providing STEMI-related PCI increased from 2003 to 2011, whereas in-hospital
death rates decreased. PCI was an important mediator of decreasing mortality in this nationally representative
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140S T-segment elevation myocardial in-farction (STEMI) is the most severeform of myocardial infarction and is
associated with signiﬁcant morbidity and
mortality. Fortunately, percutaneous coro-
nary intervention (PCI) offers an evidence-
based, lifesaving treatment option (1). In
recent years, professional societies have
developed programs, such as the American
College of Cardiology Door-to-Balloon (D2B)
Initiative and the American Heart Associa-
tion Mission: Lifeline, to promote timely ac-
cess to PCI for all STEMI patients. In
addition, the recent American Heart Associa-
tion/American College of Cardiology guide-
lines add a speciﬁc focus on health care
delivery and recommend regional systems
of STEMI care to facilitate rapid access to
PCI (2).
These system-based efforts are intended
to mitigate the morbidity and mortality of
STEMI in the U.S. population by dissemi-
nating evidence-based treatment, namelyPCI, on a broader scale. Studies from the National
Cardiovascular Disease Registry (NCDR) (3) indicate
that PCI rates for STEMI are increasing. The NCDR,
however, reﬂects a narrow range of self-selected
hospitals that may not accurately represent the
diverse nation. To overcome these limitations, we
used the Nationwide Inpatient Sample (NIS), which
includes a nationally representative sample of hos-
pitals and patients, to quantify in-hospital treatment
patterns and outcomes and describe the changing
landscape of PCI availability for STEMI in the United
States. Because the PCI health care delivery initia-
tives were not tested in a randomized fashion, un-
derstanding the effects in an observational fashion is
necessary. In the process, we demonstrate that
comprehensive assessment of common conditions
and health outcomes is possible using publicly
available data and relatively simple methods.
METHODS
The NIS, part of the Healthcare Utilization Project
from the Agency for Healthcare Research and Quality,
is the largest available all-payer hospital discharge
database. Each year includes w8 million dischargesnt, analysis, and interpretation of the data; and preparation, rev
manuscript for publication. Dr. Shah is a stockholder in Gilead Sci
ships relevant to the contents of this paper to disclose.
received May 9, 2014; accepted July 2, 2014.from 1,000 hospitals; variables include demographic
factors, diagnostic and procedural codes, disposition,
and hospital characteristics (4,5). Hospitals are
selected based on 5 strata (region, bed size, hospital
control, teaching status, urban vs. rural) to approxi-
mate a 20% sample of all nonfederal, short-term U.S.
hospitals, using the American Hospital Association
survey as reference (6). All discharges from selected
hospitals are included in the dataset; in other words,
the sampling unit is the hospital. The same hospitals
are not necessarily selected for inclusion each year;
rather hospitals are selected to create a representa-
tive snapshot of U.S. hospitals for each year, and the
sampling strategy was consistent throughout the
study period. It is not possible to determine whether
separate discharges represent the same patient
because the NIS is a discharge, not patient, database.
Adult STEMI discharges from January 1, 2003, to
December 31, 2011 were included based on primary
International Classiﬁcation of Diseases-Ninth Revi-
sion (ICD-9) diagnostic code (7–9). ICD-9–based
identiﬁcation of acute myocardial infarction hospi-
talizations has been validated in several cohorts
(7,8,10,11). The speciﬁcity exceeds 90%, and the
positive predictive values range from 73% to 81%; the
predictive value of ICD-9 codes for STEMI has been
stable over time (7,10). The source of admission was
not a criterion for inclusion or exclusion, so dis-
charges transferred in from other facilities (including
emergency departments) were included.
We estimated PCI and in-hospital death rates over
time. Continuous variables were compared using
analysis of variance, and categorical variables were
compared using the chi-square test. PCI use was
determined from ICD-9 procedural codes (12). Dis-
charges to other acute care facilities or missing
disposition were excluded for outcomes analyses
because treatment patterns and mortality could not
be determined in these cases. We used logistic
regression with generalized estimating equations (to
account for clustering within hospitals) to calculate
the odds ratio (OR) of PCI and death according to
year, with adjustment for age, sex, race/ethnicity,
primary payer, comorbid conditions, and hospital
characteristics. Comorbid conditions were identiﬁed
from diagnosis codes using the risk adjustment model
developed by the Agency for Healthcare Research and
Quality (13,14); this methodology has been used iniew, or approval of the manuscript; and decision to
ences. All other authors have reported that they have
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141several other investigations, including studies
examining outcomes in acute myocardial infarction
(15). Hospital characteristics included geographic
region, teaching status, number of beds, coronary
artery bypass grafting (CABG) capability, and STEMI-
related PCI volume. Hospitals were deﬁned as CABG
capable if 2 or more discharges in a given year
included a procedure code for CABG. We included PCI
in the mortality model to account for the effect of PCI
use on death.
We examined trends in STEMI-related PCI
availability by calculating the number of hospitals
providing STEMI-related PCI according to year. First,
we classiﬁed hospitals into STEMI-related PCI volume
groups, according to the recently published “Clinical
Competence Statement on Coronary Artery Inter-
ventional Procedures” (16). STEMI-PCI discharges,
deﬁned by the presence of a primary diagnostic code
for STEMI and any procedural code for PCI, were
summed to generate a STEMI-PCI caseload per hos-
pital per year. Hospitals were classiﬁed as zero vol-
ume if the annual number of STEMI-related PCI
discharges was 0, low if the sum was >0 and <36,
and high volume if the sum was >36. We then
calculated the proportion of hospitals with zero-,
low-, and high-volume caseloads for each year of
the study; the denominator was the number
of nonfederal, acute care hospitals in the NIS for
each year. In addition, we calculated the median
(interquartile range [IQR]) number of STEMI-related
PCIs per hospital per year for all nonzero-volumeFIGURE 1 Number of STEMI Discharges and Rates of PCI and In-Hos
PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevatihospitals; these were compared nonparametrically
across time using median scores. Finally, we assessed
the proportion of STEMI discharged patients treated
at zero-, low-, and high-volume centers according
to year.
Analyses were performed using Stata software
version 12 (StataCorp, College Station, Texas), and a
2-sided p value <0.05 was considered statistically
signiﬁcant.
RESULTS
From 2003 to 2011, we identiﬁed 380,254 STEMI dis-
charges in the NIS, with fewer discharges in each year
of the study (Figure 1). Total discharges to other acute
care facilities accounted for 9.23% (N ¼ 35,103) of
STEMI hospitalizations, decreasing from 13.8% to
4.8% over the study period. After excluding these
transfers and discharges with missing disposition
(n ¼ 305), 344,846 discharges remained for outcome
analyses. Discharged patients from later years were
younger and more likely to be male, diabetic, hyper-
tensive, and uninsured (Table 1). Including all years,
67.8% (n ¼ 233,684) of hospital discharges included
PCI and 8.1% of patients (n ¼ 28,020) died in-hospital.
The PCI treatment rate increased during the study
period from 53.6% in 2003 to 80.0% in 2011 (Figure 1).
After adjustment, the OR of PCI was more than 4
times higher in 2011 compared with 2003 (OR: 4.16
in 2011 vs. 2003, 95% CI: 3.71 to 4.66) (Figure 2A).
Concomitant with the increasing PCI rate, anpital Death in the United States, 2003 to 2011
on myocardial infarction.
TABLE 1 Characteristics of STEMI Discharges According to 3-Year Intervals
Variable
2003, 2004, 2005
(n ¼ 152,999)
2006, 2007, 2008
(n ¼ 124,162)
2009, 2010, 2011
(n ¼ 103,093)
Demographic factors
Age, yrs 64.55  14.35 63.57  14.32 62.97 (13.91)
Age, yrs 64 (54–76) 62 (53–75) 62 (53–73)
Female 54,389 (35.55) 41,479 (33.41) 32,584 (31.61)
Primary payer
Medicare 73,521 (48.05) 54,579 (43.96) 43,232 (41.93)
Private 55,923 (36.55) 47,475 (38.24) 38,261 (37.11)
Medicaid 8,131 (5.31) 6,675 (5.38) 7,123 (6.91)
Other, including self-pay 15,198 (9.93) 15,194 (12.24) 14,185 (13.76)
Race/ethnicity
White 86,894 (56.79) 73,357 (59.08) 68,525 (66.47)
Black 7,551 (4.94) 6,685 (5.38) 6,951 (6.74)
Hispanic 8,023 (5.24) 6,514 (5.25) 6,587 (6.39)
Asian/Paciﬁc Islander 2,186 (1.43) 2,006 (1.62) 2,132 (2.07)
Other 2,607 (1.70) 3,839 (3.09) 4,104 (3.98)
Missing 44,738 (29.24) 31,761 (25.58) 14,794 (14.35)
Comorbid conditions
Chronic pulmonary disease 23,894 (15.62) 19,471 (15.68) 15,054 (14.60)
Depression 5,335 (3.49) 5,573 (4.49) 5,434 (5.27)
Diabetes 36,325 (23.74) 31,431 (25.31) 27,983 (27.14)
Hypertension 77,451 (50.62) 70,767 (57.00) 63,749 (61.84)
Hypothyroidism 8,661 (5.66) 8,071 (6.50) 7,474 (7.25)
Liver disease 960 (0.63) 956 (0.77) 967 (0.94)
Hospital characteristics
CABG capable 114,321 (74.72) 100,071 (80.60) 85,637 (83.07)
No. of beds
Small 13,183 (8.62) 12,104 (9.75) 8,440 (8.19)
Medium 36,037 (23.55) 28,519 (22.97) 20,749 (20.13)
Large 103,762 (67.82) 83,438 (67.20) 72,236 (70.07)
Missing 17 (0.01) 101 (0.08) 1,668 (1.62)
Rural hospital 16,312 (10.66) 11,434 (9.21) 8,435 (8.18)
Hospital region
Northeast 28,414 (18.57) 20,411 (16.44) 18,700 (18.14)
Midwest 3,382 (2.21) 29,100 (23.44) 24,369 (23.64)
South 62,280 (40.71) 51,256 (41.28) 39,315 (38.14)
West 28,423 (18.58) 23,395 (18.84) 20,709 (20.09)
Teaching hospital 69,528 (45.44) 60,134 (48.43) 51,297 (49.76)
PCI volume
0 29,024 (18.97) 12,530 (10.09) 5,053 (4.90)
1–36 STEMI-related PCIs/yr 9,927 (6.49) 7,764 (6.25) 7,254 (7.04)
>36 STEMI-related PCIs/yr 114,048 (74.54) 103,868 (83.66) 90,786 (88.06)
Values are mean  SD, median (interquartile range), or n (%). Note: Numbers do not always equal 100% due to
missing data.
CABG ¼ coronary artery bypass grafting; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment
elevation myocardial infarction.
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142increasing proportion of U.S. hospitals provided PCI
for STEMI during the study period. In 2003, 25.1% of
hospitals provided PCI for STEMI compared with
33.7% in 2011 (Figure 3). The number of high-volume
PCI centers, $36 STEMI-related PCIs/year, increased
from 19.8% to 23.6% (Figure 3). In addition, increasing
proportions of STEMI discharges were from high-
volume centers over time, 73.8% in 2003 compared
with 88.2% in 2011 (Figure 3).Although more hospitals provided STEMI-related
PCIs and more patients were treated at high-
volume centers, the case volume of STEMI-related
PCIs per hospital decreased. In 2003 (including
only non-zero-volume hospitals), the median num-
ber of STEMI-related PCIs per hospital was 84 (IQR:
46 to 133) compared with 63 (IQR: 30 to 100) in 2011
(p ¼ 0.04).
In-hospital death rates for STEMI ranged from 7.2%
to 9.5% during the study period. The unadjusted
death rate was highest in 2003, and the lowest was in
2009 (Figure 1). After adjustment for demographic
factors, comorbid conditions, and hospital charac-
teristics, the OR of death decreased through 2010 and
was similar in the ﬁnal 2 years of the study (OR: 0.79
in 2011 vs. 2003; 95% CI: 0.74 to 0.84) (Figure 2B). PCI
attenuated the effect of year on death; after inclusion
of PCI in the model, the ORs of death were similar in
all years of the study (Figure 2C).
DISCUSSION
Our study of STEMI in the United States, which
included a broad spectrum of payers, ages, and hos-
pitals, demonstrates 3 important observations: PCI
reperfusion rates for STEMI increased signiﬁcantly
between 2003 and 2011, in-hospital mortality rates
decreased and PCI was a mediator of this decrease,
and the proportion of hospitals providing PCI for
STEMI increased.
First, these ﬁndings suggest that initiatives
emphasizing access to PCI have been successful; the
odds of undergoing PCI during STEMI hospitalization
increased more than 4-fold in less than a decade.
Similar trends are present in smaller, more selective
U.S. cohorts and other countries. The NCDR Acute
Coronary Treatment and Intervention Outcomes
Network Registry–Get With The Guidelines (ACTION
Registry–GWTG), for example, reported PCI rates of
75% and 85% in 2007 and 2009, respectively,
compared with 70% and 80%, respectively, in our
sample (3). By 2011, the NCDR rate was 87.9% (17)
compared with our 80.0% rate. This difference may
be explained by greater interhospital variability
because smaller rural hospitals are less likely to be
included in the NCDR. In France, the PCI rate
increased from 61.5% to 86.7% over 10 years (18).
The proportion of U.S. hospitals providing STEMI-
related PCI increased between 2003 and 2011,
whereas the total number of STEMI discharges
decreased. This ﬁnding parallels the ﬁnding of a
recent report using the American Hospital Association
survey that demonstrated an increasing number of
PCI-capable hospitals in the United States (19).
FIGURE 2 Adjusted ORs of PCI and Death According to Year
(A) PCI model includes year, age, sex, race/ethnicity, payer, comorbid conditions as deﬁned by the Agency for Healthcare Research and Quality
model for risk adjustment, number of hospital beds, rural hospital, region, hospital teaching status, ST-segment elevation myocardial
infarction–PCI volume category, coronary artery bypass grafting capability. (B) Adjusted ORs of death according to year, excluding PCI.
Mortality model includes all variables in the PCI model. (C) Adjusted ORs of death according to year, including PCI. Mortality model includes all
variables in the PCI model plus PCI. CI ¼ conﬁdence interval; OR ¼ odds ratio; PCI ¼ percutaneous coronary intervention.
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143Although the expanding hospital supply may have
contributed to higher PCI rates for STEMI, increased
capability resulted in a lower case volume per hos-
pital. This pattern will amplify if the total number of
STEMI hospitalizations continues to decrease and the
number of PCI-capable hospitals continues to in-
crease. Health care delivery systems and regulatory
agencies need to focus on optimized expansion of PCI
capabilities to balance demand, access, and caseload
to maintain proﬁciency (20).Concomitant with PCI changes, in-hospital mor-
tality for STEMI decreased between 2003 and 2011.
The adjusted OR of death decreased more than 25%
between 2003 and 2010 and then stabilized through
2011. Death rates reported in this nationally repre-
sentative sample, however, are higher than rates
reported in the ACTION Registry–GWTG (3,17). One
possible explanation is that higher performing hos-
pitals preferentially participate in the registry, and
those hospitals select which cases are entered into
FIGURE 3 Number of STEMI Discharges From Hospitals According to Case Volume and Proportion of Hospitals Providing STEMI-Related PCI
Colored bars and left-hand axis indicate the proportion of discharges from zero- (no STEMI-related PCIs), low-, and high- (more than 36
STEMI-related PCIs/year) volume centers according to year. By 2011, discharges were clustered into high-volume centers, and few patients were
discharged from zero-volume centers. Black lines and right-hand axis indicate the proportion of hospitals providing STEMI-related PCI. By 2011,
the proportion of hospitals STEMI-related PCI increased. Abbreviations as in Figure 1.
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144the registry, thus favorably biasing the outcomes by
“cherry picking.” This possibility is exempliﬁed
by the fact that our data include 43,663 STEMI
discharges (11.6%) from facilities that provided no
STEMI-related PCIs; such patients are unlikely to be
included in registries.
Death rates stabilized in the ﬁnal 2 years of the
study, and after accounting for PCI, in-hospital mor-
tality did not change between 2003 and 2011. Simi-
larly, the ACTION Registry–GWTG reported a decrease
in adjusted in-hospital mortality from 2007 to 2009,
from 6.2% to 5.5% (3). A more recent publication re-
ports a 5.9% in-hospital death rate for STEMI in 2011
(17), so the NCDR investigators also may report a
similar stall in their next trend analysis. In addition, a
report from Worcester, Massachusetts, showed no
change in in-hospital mortality through 2005 (21),
and a report from Kaiser Permanente of Northern
California showed no change in the 30-day mortality
rate after STEMI through 2008 (7). These ﬁndings, in
combination with our results, suggest that we need
to devise new initiatives to continue improved STEMI
in-hospital outcomes.
Finally, this investigation was completed with
publicly available data and demonstrates the feasi-
bility comprehensive surveillance of common condi-
tions. We captured important trend data to inform
decision making related to STEMI care in the United
States using relatively simple methods. The AmericanRecovery and Reinvestment Act of 2009 created
ﬁnancial incentives to adopt meaningful use of elec-
tronic health records, and several professional soci-
eties now promote standardized data collection via
electronic health records (22,23). As a result, the
availability and quality of electronic data will
improve such that future investigations will over-
come current limitations, including case identiﬁca-
tion and risk adjustment. These advances should
create opportunities for public cardiovascular health
surveillance in an effort to improve the health of the
country (24).
STUDY LIMITATIONS. The NIS is an administrative
database that allows inclusion of a large number of
hospitals and patients in the United States at the
cost of clinical detail. First, we could not estimate
the number of discharged patients who underwent
thrombolysis or were reperfusion ineligible using
ICD-9 procedure codes; these cases may account
for a proportion of discharged patients who did not
undergo a PCI, particularly in the early years of the
study. We relied on ICD-9 codes among patients who
survived to hospitalization for case identiﬁcation.
Although this method has been validated for acute
myocardial infarction in different cohorts, our data
include hospitals not typically represented in regis-
tries and clinical trials; coding practices may vary
according to hospital.
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145The NIS lacks clinical detail; registries such as
ACTION Registry–GWTG provide more detail to ac-
count for the effects of medications and other
important determinants of STEMI outcomes. A recent
publication, however, suggests that faster D2B times
among patients who undergo a PCI do not improve
STEMI outcomes (25); this clinical detail, therefore,
may not have altered our results. We could not pre-
cisely deﬁne comorbid conditions for comprehensive
risk adjustment, so it is possible that STEMI patients
were sicker over time.
CONCLUSIONS
STEMI-related PCI use increased signiﬁcantly from
2003 to 2011 in the United States, and more hospitals
provided this service over time. These changes
occurred during an era of systemwide efforts to
expand PCI treatment to all STEMI patients, including
the American College of Cardiology D2B Initiative and
the American Heart Association Mission: Lifeline. Our
ﬁndings are encouraging and suggest that wide-scale
health service improvements can have a positive
impact.However, these favorable mortality trends have
plateaued in recent years. Continued reﬁnement of
in-hospital care, such as D2B time, has diminishing
returns for improved outcomes (25). The focus must
now shift to other health service initiatives to
improve STEMI outcomes, including optimizing pre-
hospital care (26). In addition, future studies should
focus on identifying sources of variation in STEMI
outcomes, such as patient-level variation (e.g., low
socioeconomic status and comorbid conditions) and
hospital-level variation (e.g., rural and lower volume
centers). These types of investigations will help to
identify areas for targeted delivery strategies and
help get valuable treatment to the patients who need
it most.
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